_:n55d141e72f6d4c8b89506d3649dcaaf9xb0
<http://schema.org/description>
"Looking into Medicare Part D Costs\nWho really makes money on brand-name drugs?\nAs the discussion about the Medicare Part D drug costs gets more heated, the real story behind the problem is becoming clear.\nThese are the two issues and how they affect you:\nMoney made by drug middlemen (who negotiate drug prices). This keeps the price of many critical drugs very high.\nBig Pharma’s monopoly on brand drugs and opposition to lower-priced generics. This gives you no alternative to paying high prices for certain drugs.\nMedicare is at the mercy of the drug middlemen – pharmacy benefit managers (PBMs) – when it comes to drug prices. Medicare is prevented by law from negotiating directly with the drug manufacturers. There was some hope when President Trump promised during his campaign that he would remedy that law. Medicare would negotiate prices and the PBMs would not. However, the latest legislation has the PBMs still in charge. Why does the fox in the henhouse come to mind?\n........"
<https://medicareonvideo.com/medicare-alphabet/>